Poster zum Thema "Glial, glioneuronal and embryonal tumors II"

Zurück
  • PS6-NO-A57
A novel definition of low-grade astrocytoma IDH-mutant to inform observational follow-up and the upcoming era of IDH mutant inhibitors
  • Franck Bielle (Paris, FR)
  • PS6-NO-A58
Beyond IDH1 R132H mutation – clinicopathological characteristics of non-canonical IDH mutant gliomas
  • PS6-NO-A59
Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma
  • PS6-NO-A60
Comprehensive genomic profiling of ATRX-deficient IDH-wildtype adult high-grade gliomas reveals clinically relevant genetic patterns
  • PS6-NO-A61
Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience
  • PS6-NO-A62
Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)
  • PS6-NO-A63
Adult medulloblastoma – clinico-molecular spectrum, an institutional experience
  • PS6-NO-A64
DNA methylation profiling of adult spinal glial tumours – results from a large single centre study
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH